KIT mutations and CD117 overexpression are markers of better progression-free survival in vulvar melanomas

D. Dias-Santagata, M.A. Selim, Y. Su, Y. Peng, R. Vollmer, A. Chłopik, G. Tell-Marti, K.M. Paral, S.C. Shalin, C.R. Shea, S. Puig, M.T. Fernandez-Figueras, W. Biernat, J. Ryś, A. Marszalek, M.P. Hoang
  • British Journal of Dermatology, November 2017, Wiley
  • DOI: 10.1111/bjd.15836

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1111/bjd.15836

The following have contributed to this page: Susana Puig and Dr María Teresa Fernández Figueras